Carolina Blood and Cancer Care of South Carolina

Rock Hill, South Carolina 29732

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Sickle Cell Disease (SCD)

Studies at this site

• Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC) — Completed
• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib — Stopped early